drugset / Trial / NCT05301894
Extension Study to Evaluate NBI-827104 in Pediatric Participants With Epileptic Encephalopathy With Continuous Spike-and-Wave During Sleep
NaSingle-groupOpen-labelTreatment
Summary
The primary objective for this study is to evaluate the long-term safety and tolerability of NBI-827104 in pediatric participants with epileptic encephalopathy with continuous spike-and-wave during sleep (EECSWS).
Timeline
- Start
- 2022-06-07
- Primary completion
- 2025-01-27
- Completion
- 2025-01-27
Outcome
Outcome not reported
Stopped (Business): “Business decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APINOCALTAMIDE | Small molecule | — | Oral |